Known for its innovative and patient-centered approach, the clinic serves as a leader in weight loss management ...

Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

The British Medical Association has warned Northern Ireland people not to view weight loss injections as ‘a quick fix’, and ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Eli Lilly has received approval to start selling its weight loss drug, Mounjaro ... has announced that it will not cover Eli ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Opens in a new tab or window ... adults with obesity, weight loss results with 25 mg of oral semaglutide, and risk reduction ...

Eli Lilly's Mounjaro joins list of obesity and diabetes drugs made popular by celebrities who lost weight The latest ...